Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhancer-Gene Interaction Analyses Identified the Epidermal Growth Factor Receptor as a Susceptibility Gene for Type 2 Diabetes Mellitus.

Diabetes & metabolism journal - 1 Mar 2021

Yang Yang, Yao Shi, Ding Jing-Miao, Chen Wei, Guo Yan

Abstract excerpt

Background: Genetic interactions are known to play an important role in the missing heritability problem for type 2 diabetes mellitus (T2DM). Interactions between enhancers and their target genes play important roles in gene regulation and disease pathogenesis. In the present study, we aimed to identify genetic interactions between enhancers and their target genes associated with T2DM. Methods: We performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epistasis, Genetic

Share to ErbB Receptors

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 32602275
DOI: 10.4093/dmj.2019.0204
PMCID: PMC8024152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhancer-Gene Interaction Analyses Identified the Epidermal Growth Factor Receptor as a Susceptibility Gene for Type 2 Diabetes Mellitus.PMID 32602275Read ↗

Leveraging putative enhancer-promoter interactions to investigate two-way epistasis in Type 2 Diabetes GWAS.Semantic proximity Read ↗

Pancreatic Islet Transcriptional Enhancers and Diabetes.Semantic proximity Read ↗

A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.Semantic proximity Read ↗

Regulation of inflammation in diabetes: From genetics to epigenomics evidence.Semantic proximity Read ↗

Genetic and epigenetic regulation of gene expression in pancreatic isletsSemantic proximity Read ↗

Integrative analysis of super enhancer SNPs for type 2 diabetes.Semantic proximity Read ↗

Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.Semantic proximity Read ↗

In silico functional and pathway analysis of risk genes and SNPs for type 2 diabetes in Asian population.Semantic proximity Read ↗

A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.Semantic proximity Read ↗

Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.Semantic proximity Read ↗

Functional mechanisms for type 2 diabetes-associated genetic variants.Semantic proximity Read ↗

Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin loopingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.